Advanced Neoplasms research hub

Study of E7386 in Participants With Selected Advanced Neoplasms

This study is testing a new medicine, E7386, for people with certain advanced cancers. Researchers want to see if it's safe, what side effects it might cause, and find the best dose to use in future studies. It's an early-stage trial.